6.17
前日終値:
$6.29
開ける:
$6.29
24時間の取引高:
85,197
Relative Volume:
0.43
時価総額:
$53.06M
収益:
$44.33M
当期純損益:
$16.05M
株価収益率:
18.87
EPS:
0.3269
ネットキャッシュフロー:
$3.85M
1週間 パフォーマンス:
+4.05%
1か月 パフォーマンス:
-38.30%
6か月 パフォーマンス:
-77.11%
1年 パフォーマンス:
-83.96%
Sanuwave Health Inc Stock (SNWV) Company Profile
Compare SNWV vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
1.44 | 2.64B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.65 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.28 | 375.29M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
4.08 | 281.75M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
48.41 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 開始されました | Northland Capital | Outperform |
| 2025-07-29 | 開始されました | Roth Capital | Buy |
Sanuwave Health Inc (SNWV) 最新ニュース
SNWV|SNWV|Price:6.170|Chg%:+0.240 - TradingKey
Calendrier des PAPE pour: - Yahoo Finance France
What's going on with SANUWAVE Health stock on Friday? - MSN
Sanuwave Q2 revenue exceeds revised guidance on record consumable sales - scanx.trade
What's Going On With SANUWAVE Health Stock On Friday? - Benzinga
SANUWAVE Health (SNWV) Stock Forum and Discussion - Moomoo
Sanuwave sees Q2 revenue up to $9.8M - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance - Ortho Spine News
Sanuwave Health preliminary revenue increases up to 5% in Q2 2026 - Medical Buyer
Sanuwave Health (SNWV) Raises Q2 Revenue Expectations to $9.6M-$9.8M - GuruFocus
Sanuwave Health Reports Q2 2026 Revenue Above Guidance Amid Record Consumable Sales and Used System Market Growth - Minichart
Sanuwave Health (SNWV) Reports Second Quarter Revenue Expectatio - GuruFocus
Sanuwave Health, Inc. Revises Earnings Guidance for the Second Quarter Ended June 30, 2026 - marketscreener.com
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance By Investing.com - Investing.com Nigeria
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance - Investing.com
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6-$9.8 Million, Above High End of Revised Guidance - The Manila Times
Sanuwave Health Reports Preliminary Second Quarter 2026 Revenue Above Revised Guidance Range - Quiver Quantitative
Press Release: Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6--$9.8 Million, Above High End of Revised Guidance - Moomoo
A Look at SANUWAVE Health Inc (SNWV) After 3.4% Decline -- GF Va - GuruFocus
SANUWAVE Health (SNWV) director granted 5,524 fully vested stock options - Stock Titan
SANUWAVE Health (SNVW) director granted 5,524 $10 options - Stock Titan
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2000 Dynamic Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000E Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell Small Cap Completeness Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2500 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 3000 Growth Benchmark - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Sanuwave Health, Inc. Actuals & Estimates (NASDAQ:SNWV) - TradingView
SNWV Q1 2026 Earnings: Wider-Than-Expected Loss Dampens Investor SentimentAnalyst Drop Coverage - DonanımHaber
SNWV Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Stock Rises 4.51%EPS Growth Rate - dars.gov.et
SANUWAVE Health (SNWV) Faces Selling Pressure, Tests Key Support After 4.66% DeclineFactor Rotation - dars.gov.et
SNWV Q1 2026 Earnings: Larger-Than-Expected Loss as Revenue Remains UndisclosedProfit Margin Analysis - dars.gov.et
SNWV: UltraMIST leverages clinical evidence and a consumables model to drive growth amid industry shifts - TradingView
Sanuwave Health eyes revenue up to USD 9.5M in Q2 2026 - Medical Buyer
Sanuwave Health expects Q2 revenue of $8.5M-$9.5M - scanx.trade
Top Midday Decliners - Moomoo
Sanuwave cuts Q2 revenue guidance on weak equipment sales By Investing.com - Investing.com South Africa
Sanuwave Health, Inc. Updates Earnings guidance for the Second Quarter 2026 - marketscreener.com
Sanuwave Health Cuts Q2 Revenue Guidance Amid Market Pressures - TipRanks
Sanuwave cuts Q2 revenue guidance on weak equipment sales - Investing.com
Sanuwave Health Updates Second Quarter 2026 Guidance - The Manila Times
Sanuwave updates Q2 revenue guidance to $8.5–$9.5M, applicator demand strong despite Ultramist headwinds - TradingView
Press Release: Sanuwave Health Updates Second Quarter 2026 Guidance - Moomoo
Sanuwave Health shareholders elect directors and approve auditor at annual meeting - Investing.com
Sanuwave Health Stockholders Approve Directors and Governance Matters - TipRanks
SANUWAVE Health (SNWV) Retreats From Resistance, Testing Key Support LevelsLast Point Support - newsline.com
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Stock RallyRevenue Warning Signal - newsline.com
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates; Stock Rises Despite Wider LossROE Trend Analysis - newsline.com
SNWV: Director elections, auditor ratification, and executive pay were voted on; results pending - TradingView
Sanuwave Health Inc (SNWV) 財務データ
収益
当期純利益
現金流量
EPS
Sanuwave Health Inc (SNWV) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
May 01 '26 |
Sale |
16.11 |
10,581 |
170,465 |
5,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 28 '26 |
Sale |
18.47 |
46,288 |
854,819 |
7,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 29 '26 |
Sale |
17.25 |
24,360 |
420,152 |
6,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 17 '26 |
Sale |
20.46 |
16,267 |
332,841 |
10,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 21 '26 |
Sale |
20.50 |
202 |
4,142 |
954,798 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 11 '25 |
Sale |
31.28 |
13,500 |
422,277 |
70,499 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 12 '25 |
Sale |
21.04 |
6,500 |
136,789 |
63,999 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 08 '25 |
Sale |
30.75 |
125,400 |
3,856,050 |
881,390 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 09 '25 |
Sale |
30.58 |
8,785 |
268,679 |
872,605 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 10 '25 |
Sale |
30.39 |
8,625 |
262,129 |
863,980 |
大文字化:
|
ボリューム (24 時間):